PHASE 2 TRIAL OF GAMUNEX ( INTRAVENOUS GAMMAGLOBULIN) FOR SICKLE CELL ACUTE PAIN
Federal financial assistance recorded from USAspending. This is not a procurement contract.
Research this with AI
Research smarter with AI
Analyze opportunities and compare insights across leading AI models.
ASST_NON_R01FD005341_075 · ALBERT EINSTEIN COLLEGE OF MEDICINE · Department of Health and Human Services
Compare Multiple AI Models with SmartSoloExplore CaptureIQ IntelligenceAssistance award details
- Assistance award identifier
- ASST_NON_R01FD005341_075
- FAIN
- R01FD005341
- Recipient
- ALBERT EINSTEIN COLLEGE OF MEDICINE
- Awarding agency
- Department of Health and Human Services
- Funding agency
- —
- Assistance listing (CFDA)
- 93.103
- Total obligated
- $1,597,656
- Period
- Sep 10, 2015 – Jul 31, 2019
- Fiscal year
- 2015
- Place of performance state
- NY
- Source file
- FY2015_All_Assistance_Full_20261006.zip
Description
PHASE 2 TRIAL OF GAMUNEX ( INTRAVENOUS GAMMAGLOBULIN) FOR SICKLE CELL ACUTE PAIN